DSS.AMEXDss, INC

DEF 14A: DSS, Inc. Sets 2025 Annual Meeting Agenda, Reveals Financial Details

Sentiment:

Proxy Statement


๐Ÿ“‹All filings for Dss, INC

DSS, Inc. announces its 2025 Annual Meeting of Stockholders to vote on director elections, auditor ratification, and executive compensation, while disclosing significant related party transactions and financial reserves.

Delay expectedThe $1,000,000 promissory note with VEII, Inc., originally due on July 26, 2024, was amended to extend its maturity date to July 26, 2025.
Capital raiseOn December 10, 2024, DSS entered into a private placement agreement to sell 820,597 shares of common stock to Alset Inc. for approximately $803,000.On December 10, 2024, DSS entered into a private placement agreement to sell 205,149 shares of common stock to Ambrose Chan Heng Fai for approximately $197,000.
Worse than expectedThe company reported an unrealized loss of approximately $750,000 on its investment in Alset International Limited for the year ended December 31, 2024.Promissory notes to BMI Capital, Inc. totaling approximately $196,000 were fully reserved for as of December 31, 2024, indicating a high likelihood of non-recovery.Approximately $480,000 of a $1,000,000 promissory note to VEII, Inc. was reserved for as of March 31, 2024, suggesting significant doubt about its collectability.Former CEO Frank D. Heuszel's total compensation decreased significantly from $675,196 in 2023 to $275,142 in 2024, which could reflect a decline in company performance or a change in compensation philosophy.

Summary

  • The 2025 Annual Meeting of Stockholders for DSS, Inc. will be held on December 3, 2025, at 9:00 a.m. Eastern time.
  • Stockholders will vote on the election of 7 director nominees, the ratification of HTL International, LLC. as the independent registered public accounting firm for fiscal year 2025, and an advisory vote on executive compensation.
  • The Board of Directors recommends a 'FOR' vote on all proposals.
  • The record date for stockholders entitled to vote is October 6, 2025, with 9,092,518 shares of common stock outstanding.
  • The company disclosed significant related party transactions, including private placements of common stock to Alset Inc. and Chairman Ambrose Chan Heng Fai in December 2024, totaling approximately $1 million.
  • Substantial reserves were made against related party promissory notes, indicating potential non-recovery, and the company recorded unrealized losses on an investment in Alset International Limited.
  • Frank D. Heuszel stepped down as CEO on August 23, 2024, and Jason Grady was appointed Interim Chief Executive Officer, with both Mr. Grady and CFO Todd D. Macko currently on month-to-month interim employment agreements.

Sentiment

Score: 3

Explanation: The filing reveals significant unrealized losses on investments and substantial reserves against related party notes, indicating potential financial strain or poor asset quality. Executive compensation for key officers is on interim, month-to-month agreements, creating uncertainty. While it's a routine proxy, these financial details are concerning.

Positives

  • The Board of Directors recommends a 'FOR' vote on all proposals, including director elections, auditor ratification, and executive compensation.
  • The Audit Committee reported no adverse opinion or disclaimer from the previous auditor, Grassi & Co., for the fiscal year ended December 31, 2024, and no disagreements on accounting principles or procedures.
  • The Board believes that the company's compensation program does not encourage excessive or inappropriate risk-taking by employees.

Negatives

  • The company recorded an unrealized loss of approximately $750,000 on its investment in Alset International Limited for the year ended December 31, 2024, following a $50,000 unrealized loss in 2023.
  • Promissory notes to BMI Capital, Inc. totaling approximately $196,000 ($86,000 and $110,000) were fully reserved for as of December 31, 2024, indicating a high risk of non-recovery.
  • Approximately $480,000 of a $1,000,000 promissory note to VEII, Inc. was reserved for as of March 31, 2024, suggesting significant doubt about its collectability.
  • Former CEO Frank D. Heuszel's total compensation decreased significantly from $675,196 in 2023 to $275,142 in 2024.
  • Interim CEO Jason Grady and CFO Todd D. Macko are currently operating under month-to-month interim employment agreements, with no bonus accrued or payable for Mr. Grady during his interim COO period, indicating executive contract uncertainty.

Risks

  • The company faces uncertainty regarding the long-term employment agreements for its Interim CEO and CFO, who are currently on month-to-month contracts.
  • There is a significant risk of non-recovery on related party promissory notes, as evidenced by the full reservation of notes to BMI Capital, Inc. and partial reservation of a note to VEII, Inc.
  • The non-binding nature of the advisory vote on executive compensation means that stockholder disapproval may not lead to changes in compensation practices.
  • The company's financial health and operations may be influenced by its complex network of related parties and inter-company transactions, which could pose governance and financial risks.

Future Outlook

The filing primarily details the agenda for the upcoming 2025 Annual Meeting of Stockholders and provides historical financial and governance information. It does not offer specific forward-looking financial guidance, strategic projections, or operational outlook beyond the standard proposals for the meeting.

Management Comments

  • The Board of Directors recommends that stockholders vote FOR the election of all director nominees, the ratification of the independent registered public accounting firm, and the advisory resolution to approve executive compensation.
  • The Board believes that the design of our compensation program does not motivate imprudent risk-taking.

Industry Context

This filing is a standard proxy statement detailing corporate governance matters, director elections, and executive compensation for DSS, Inc. It does not provide a broader analysis of industry trends or the company's competitive position within its operating sectors. However, the extensive network of related parties and inter-company transactions involving entities like Alset Inc. and Alset International Limited suggests a complex corporate ecosystem that may influence its industry standing and operational focus.

Comparison to Industry Standards

  • The filing does not provide specific comparisons to industry benchmarks, comparable companies, projects, or results.

Management Changes

RolePrevious PersonNew PersonEffective DateReason
Chief Executive Officer and Board MemberFrank D. HeuszelNAAugust 23, 2024Stepped down to accept a role as Chief Executive Officer of Impact BioMedical, Inc., a subsidiary of DSS.
Interim Chief Executive OfficerNAJason GradyAugust 23, 2024Elected by the Board of Directors following the resignation of the previous CEO.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Director ElectionElection of 7 director nominees to the Board of Directors to hold office until the next Annual Meeting of Stockholders.December 3, 2025 (upon stockholder vote)Ensures continuity of board leadership and oversight.
Auditor RatificationRatification of the appointment of HTL International, LLC. as the company's independent registered public accounting firm for the fiscal year ending December 31, 2025.December 3, 2025 (upon stockholder vote)Confirms the independent auditor for financial statement audits and reviews, crucial for financial transparency and regulatory compliance.
Advisory Vote on Executive CompensationA non-binding advisory vote on executive compensation, providing stockholders an opportunity to approve or not approve the compensation disclosed.December 3, 2025 (upon stockholder vote)Provides stockholder feedback on executive compensation, which the Compensation and Management Resources Committee will consider for future arrangements, though it is not binding.
Leadership StructureThe positions of Chief Executive Officer and Chairman of the Board are held by two different individuals (Ambrose Chan Heng Fai as Chairman, Jason Grady as Interim CEO).OngoingAllows the CEO to focus on daily business strategies and the Chairman on long-term strategic direction, potentially enhancing oversight and management focus.

Related Party Transactions

  • DSS owns approximately 4% of Alset International Limited, a company whose Chairman/CEO is Ambrose Chan Heng Fai (DSS Chairman and largest shareholder). The investment had a fair value of $2,518,000 as of December 31, 2024, and resulted in an unrealized loss of $750,000 in 2024.
  • DSS Financial Management Inc. entered into a $100,000 promissory note (Note 8) with BMI Capital, Inc. (DSS owns 24.9% of BMIC) on August 29, 2022, due August 29, 2025. The outstanding principal and interest of approximately $86,000 was fully reserved for as of December 31, 2024.
  • DSS Financial Management Inc. entered into a $102,000 promissory note (Note 9) with BMI Capital, Inc. on May 8, 2023, due May 7, 2026. The outstanding principal and interest of approximately $110,000 was fully reserved for as of December 31, 2024.
  • APF entered into a $1,000,000 promissory note (Note 10) with VEII, Inc. (Ambrose Chan Heng Fai is on its board) on July 26, 2022, with the maturity date amended to July 26, 2025. The outstanding principal and interest was approximately $959,000 on September 30, 2024, with $480,000 reserved as of March 31, 2024.
  • LVAM entered into a $3,000,000 loan agreement with BMI Capital, Inc. (BMIC Loan) on October 13, 2021, with $463,000 included in current portion of long-term debt as of December 31, 2024.
  • LVAM entered into a $3,000,000 loan agreement with Lee Wilson Tsz Kin (Wilson Loan) on October 13, 2021, with $145,000 included in current portion of long-term debt as of December 31, 2024.
  • On December 10, 2024, DSS sold 820,597 shares of common stock to Alset Inc. (a related party) for approximately $803,000 in a private placement.
  • On December 10, 2024, DSS sold 205,149 shares of common stock to Ambrose Chan Heng Fai (Chairman of the Board and a related party) for approximately $197,000 in a private placement.
  • On February 6, 2025, 1,000,000 shares of common stock were awarded to Heng Fai Holdings Limited (beneficially owned by Ambrose Chan Heng Fai) as a bonus for services rendered.
  • Frank D. Heuszel had a consulting agreement with APB (a related party) for $120,000 annually, which was terminated in June 2024.
  • Ambrose Chan Heng Fai has a consulting agreement with DSS which pays him $120,000 annually.
  • Lim Sheng Hon Danny has a consulting agreement with DSS which pays him $50,000 annually.

Stakeholder Impact

  • Shareholders will directly participate in corporate governance by voting on director elections, auditor ratification, and executive compensation, influencing the company's future direction and oversight.
  • Shareholders are impacted by the company's financial performance, including unrealized losses on investments and potential non-recovery of related party notes, which could affect share value.
  • The recent private placement of common stock to related parties could lead to dilution for existing shareholders.
  • Executive officers, particularly the Interim CEO and CFO, face uncertainty due to month-to-month interim employment agreements, which could impact morale and long-term strategic planning.
  • Creditors involved in related party loans (e.g., BMI Capital, Inc., Lee Wilson Tsz Kin) are impacted by the company's ability to manage and repay these debts.

Next Steps

  • Hold the Annual Meeting of Stockholders on December 3, 2025, to vote on the proposed matters.
  • Stockholders to submit proxy votes by the Annual Meeting date.
  • The Compensation and Management Resources Committee will take into account the outcome of the advisory vote on executive compensation when considering future arrangements.

Key Dates

DateDescription
January 2017Ambrose Chan Heng Fai first elected Director of DSS, Inc.
March 2018Ambrose Chan Heng Fai became Chairman of the Board and Chief Executive Officer of Alset Inc.
August 2019Jos Escudero first elected Director of DSS, Inc. Jason Grady appointed Chief Operating Officer of DSS, Inc.
October 2019William Wu Wai Leung first elected Director of DSS, Inc.
September 2020Tung Moe Chan first elected Director of DSS, Inc.
October 13, 2021LVAM entered into a $3,000,000 loan agreement with BMI Capital, Inc. (BMIC Loan).
October 13, 2021LVAM entered into a $3,000,000 loan agreement with Lee Wilson Tsz Kin (Wilson Loan).
October 2021Ambrose Chan Heng Fai became Chairman of the Board of HWH International Inc.
December 2021Ambrose Chan Heng Fai became director of Value Exchange International, Inc.
January 2022William Wu Wai Leung became a member of the Board of Directors of HWH International Inc. Frankie Wong Shui Yeung became a member of the Board of Directors of Alset Capital Acquisition Corp. and Alset Inc.
July 2022Joanne Wong Hiu Pan and Frankie Wong Shui Yeung first elected Director of DSS, Inc. William Wu appointed Lead Independent Director.
July 26, 2022APF and VEII, Inc. (VEII) entered into a $1,000,000 promissory note.
August 29, 2022DSS Financial Management Inc and BMI Capital, Inc. (BMIC) entered into a $100,000 promissory note (Note 8).
May 8, 2023DSS Financial Management Inc and BMIC entered into a $102,000 promissory note (Note 9).
December 12, 2023Frank D. Heuszel and DSS, Inc. executed a letter agreement for Mr. Heuszel to act as CEO on a month-to-month basis.
December 15, 2023Jason Grady and DSS, Inc. executed a letter agreement for Mr. Grady to act as COO on a month-to-month basis.
December 15, 2023Todd Macko and DSS, Inc. executed a letter agreement for Mr. Macko to act as CFO on a month-to-month basis.
December 31, 2023Fiscal year end.
August 23, 2024Frank D. Heuszel stepped down as Chief Executive Officer and Board member of DSS, Inc. Jason Grady was elected Interim Chief Executive Officer.
December 10, 2024DSS entered into a securities purchase agreement with Alset Inc. for approximately $803,000 in common stock.
December 10, 2024DSS entered into a securities purchase agreement with Ambrose Chan Heng Fai for approximately $197,000 in common stock.
December 31, 2024Fiscal year end.
January 31, 2025Board of Directors approved the award of 1,000,000 shares of common stock to Heng Fai Holdings Limited.
February 6, 2025Heng Fai Holdings Limited was awarded 1,000,000 shares of the company's common stock as a bonus.
March 31, 2025Annual Report on Form 10-K for the fiscal year ended December 31, 2024, filed with the SEC.
June 27, 2025Deadline for stockholder proposals for the 2024 annual meeting (120 days prior to the anniversary of this year's mailing date).
July 26, 2025Amended maturity date for the $1,000,000 promissory note with VEII, Inc.
August 29, 2025Maturity date for the $100,000 promissory note (Note 8) with BMI Capital, Inc.
October 6, 2025Record date for the determination of stockholders entitled to notice of, and to vote at, the Annual Meeting.
October 21, 2025Approximate date on which proxy materials are first being provided to stockholders.
December 3, 2025Date of the 2025 Annual Meeting of Stockholders.
December 31, 2025Fiscal year end for which HTL International, LLC. is appointed as the independent registered public accounting firm.
May 7, 2026Maturity date for the $102,000 promissory note (Note 9) with BMI Capital, Inc.

Recommendation

sell

The extensive related party transactions, particularly the significant amounts fully reserved for or partially reserved against, raise serious concerns about asset quality and potential conflicts of interest. The company has incurred substantial unrealized losses on a related party investment. The reliance on interim executive agreements also signals instability. These factors suggest underlying financial weaknesses and governance risks that warrant a cautious, if not negative, outlook for investors.

Keywords

DSS, Proxy Statement, Annual Meeting, Corporate Governance, Director Election, Auditor Ratification, Executive Compensation, Related Party Transactions, SEC Filing, Financial Reporting, Stockholders, NYSE American

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.